Viscosupplementation Market Size, Share, Growth, and Industry Analysis, By Type (Single Injection, Three Injection, Five Injection), By Application (Hospitals, Clinics, Others), and Regional Forecast to 2035

•   
•   
  

  Download Free Sample to learn more about this report

    

VISCOSUPPLEMENTATION MARKET OVERVIEW

The Global Viscosupplementation Market Size was USD 1.95 billion in 2026 and is projected to reach USD 2.77 billion in 2035, exhibiting a CAGR of 3.6% during the forecast period.

Viscosupplementation is a non-invasive medical procedure whose main application is in the management of osteoarthritis (OA), especially in the knee. It means that a gel-like substance, usually the derivatives of hyaluronic acid (HA), is injected directly into the space between the affected joints. HA plays a natural role as a lubricant and a shock absorber in a healthy joint. This is a natural fluid that is destroyed in OA, causing pain, stiffness, and loss of mobility. The goal of the injected HA is to replenish the protective, mechanical, and lubricating values of the synovial fluid in the joint, providing pain relief and enhanced functionality, sometimes postponing the occurrence of more invasive surgery. The therapy is normally resorted to when the milder options, such as analgesic medications and exercise, are unsuccessful.

The Viscosupplementation Market is growing at a very high rate in the world, partly because of the increasing incidence of osteoarthritis, which can be attributed to the aging population, and partly because of the growing popularity of non-surgical, minimally invasive forms of treatment. Major markets are North America and Asia-Pacific, although the latter tends to have a prevailing or highly increasing Viscosupplementation Market Share owing to the high geriatric population and the better healthcare infrastructure. The market has been competitive, and some of the major players have been devoting themselves to creating newer and more convenient products, including single-injection formulations that are becoming a trend. Although the efficacy of Viscosupplementation may differ in different individuals and there may be controversy as to whether it should be used as a single or as a combination therapy, its application in the management of OA by the administration of high-quality of life to millions of affected patients across the globe has continued to increase.

GLOBAL CRISES IMPACTING THE VISCOSUPPLEMENTATION MARKET

The Viscosupplementation Industry Had a Negative Effect Due to Factory Closures During the COVID-19 Pandemic.

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden growth reflected by the rise in CAGR is attributable to the market’s growth and demand returning to pre-pandemic levels.

The short-term effect of the COVID-19 pandemic on the Viscosupplementation Market was too negative, mostly due to the treatment being viewed as an elective procedure. The pandemic caused the cancellation or postponement of non-essential appointments for joint injections worldwide due to widespread lockdowns and the reallocation of healthcare resources to address the pandemic. This limitation of the visits of the patients to the hospitals and the specialty clinics, along with the supply chain failures, led to a significant decrease in volumes and sales of procedures and products in the year 2020. The market, however, swiftly proved to be resilient and recorded a sharp recovery in 2021/2022 with healthcare systems normalizing and a backlog of patients needing treatment. The structural forces, the increasing global incidence of osteoarthritis, and the aging demographic are also robust, as the market can rebound to its favorable growth path, and some of the forecasts are even slightly accelerating the post-pandemic growth rate.

LATEST TRENDS

Growing Adoption of Non-Avian (Fermentation-Based) Products to Drive Market Growth

The steadily increasing usage of non-avian (fermentation-based) hyaluronic acid (HA) products is a major and speeding-up trend in the Viscosupplementation Market. Traditionally, HA was prepared using the feathers of roosters, but synthesis using bacterial fermentation has now taken over the market. The main reason behind this change is increased product safety and purity since fermentation-derived products pose a much less threat of allergic reactions in patients who may be allergic to bird proteins. In addition, it is possible to have even tighter control of the molecular weight and purity of the HA through the fermentation process, which results in a more uniform and predictable therapeutic agent. It is this attention to safer, non-animal sourced HA that is increasing confidence among patients and physicians, which establishes it as the raw material of choice in new product development.

•   
•   
  

  Download Free Sample to learn more about this report

    

VISCOSUPPLEMENTATION MARKET SEGMENTATION

By Type

Based on Type, the global market can be categorized into Single Injection, Three Injection, Five Injection.

• Single Injection: The Single Injection division is the most rapidly expanding division, which uses the highly concentrated hyaluronic acid preparations that are aimed at providing the necessary therapeutic effect in one convenient dose that is attractive to patients and physicians alike, as it decreases the number of clinic visits.

• Three Injection: The Three Injection type is a standardized, folklore type of the regimen, in which the hyaluronic acid is given three times in succession to a patient over the course of three weeks, usually once a week, to replenish the joint fluid viscoelasticity.

• Five Injection: The Five Injection type is a form of treatment that uses five distinct doses of lower-molecular-weight hyaluronic acid that is given in a five-week regimen, one of the first and most proven treatment patterns of knee osteoarthritis.

By Application

Based on the Application, the global market can be categorized into Hospitals, Clinics, Others.

• Hospitals: The Hospitals segment is an important one, especially to patients with more severe cases of osteoarthritis, patients who have multiple comorbidities, and patients who need the resources and the knowledge of a multi-specialty environment. This segment is likely to experience a rapid growth rate as a result of the infrastructure investments.

• Clinics: The largest market share is possessed by the Clinics (including Orthopedic Clinics and Ambulatory Surgical Centers or ASCs) category since Viscosupplementation is a fast, outpatient, minimally invasive procedure that best fits in specialized orthopedic clinics with a high focus on efficiency and patient convenience.

• Others: The Others segment is usually comprised of the settings which involve retail or online pharmacies (to acquire products) and rehabilitation facilities, which play a part in the total distribution and post-procedural care of patients that have undergone Viscosupplementation treatment.

MARKET DYNAMICS

Market dynamics include driving and restraining factors, opportunities, and challenges, stating the market conditions. 

Driving Factors

Rising Global Burden of Osteoarthritis to Boost the Market

The Rising Global Burden of Osteoarthritis is a major factor in the Viscosupplementation Market Growth. The gradual but accelerating increase in the world population ageing age, especially in the developed and fast-developing countries, serves directly as an indicator of an increase in the number of individuals experiencing degeneration of the joints age-related. Moreover, the worldwide obesity rates and the sedentary lifestyles create excess weight on weight-bearing joints, which hastens the progression and intensity of OA. The vast and continuously growing number of patients with chronic joint pains builds an unrelenting high-volume demand that effective and non-surgical pain management solutions will cessate the ever-growing Viscosupplementation Market.

Strong Preference for Minimally Invasive Treatments to Expand the Market             

One of the most important forces that has widened the Viscosupplementation Market is that patients are greatly inclined to minor surgical operations rather than significant surgery. Outpatient injection Viscosupplementation is a fast recovery procedure with a significantly reduced risk of illnesses compared to surgical procedures such as total knee arthroplasty. This is a strong urge to postpone or prevent the need to have a joint replacement surgery, particularly in younger and active patients. With healthcare technology still on the rise, patients are actively searching to undergo therapies that would help them manage their pain and have better joint functioning with minimal chances of disrupting their routines, which will continue to make non-surgical HA injections useful.

Restraining Factor

High Treatment Cost and Inconsistent Reimbursement Impede Market Growth

One of the most significant aspects that hinders the healthy development of the Viscosupplementation Market is the high cost of treatment and the lack of uniform and fragmented reimbursement policies by various geographies and insurance companies. The rather high cost of the HA product and the process itself can often be translated into huge out-of-pocket expenses on the part of consumers. In case of limited, uncertain, or denied insurance coverage, which is common in cases of contradictory clinical guidelines, it acts as a significant financial impediment. Such unreliability and inconsistency of insurance cover are like a huge inhibitor to accessing a patient and slow down the overall uptake of the Viscosupplementation procedures internationally.

Expansion to Non-Knee Joints Opportunities in the Market

Opportunity

One of the opportunities in the market is the extension of the use of Viscosupplementation to other joints, other than the knees, including the hip, shoulder, and ankle. Although knee osteoarthritis prevails in the market today, these other joints have painful degenerative conditions that do not have any effective non-surgical interventions. The positive clinical experimentation, along with the bigger regulatory clearances of these new body parts, would open up large pools of new revenues right away. This diversification will enable companies to access a hitherto underserved group of patients by locating Viscosupplementation as a multi-purpose joint health treatment and as a catalyst to overall market development, rather than the sole focus currently.

Variability in Clinical Efficacy Could Be a Potential Challenge

Challenge

One of the possible market and consumer obstacles is the variability and discrepancy in the medical efficacy of the reported Viscosupplementation. Although a large portion of patients are relieved of significant pain and also have better functioning, the largest medical guidelines and clinical studies contradict each other on their overall effectiveness compared to placebo or other therapies. Such uncertainty with regard to patient outcomes may create dissatisfaction among the consumers who fail to get the desired results after a very expensive procedure. This unpredictability in the effect on which a response is universally assured causes an issue of trust that should be dealt with by implementing improved patient selection criteria and ongoing R&D in order to make the treatment reliable and predictable in benefit provision.

•   
•   
  Download Free Sample to learn more about this report

    

VISCOSUPPLEMENTATION MARKET REGIONAL INSIGHTS

• North America

The state of North America is already leading in the Viscosupplementation Market in the world, due to the advanced health care system, awareness that non-surgical management is the only way to go, and reimbursement policies. The biggest player in this region is the United States Viscosupplementation Market, which is typified by the high incidence of osteoarthritis, a great presence of major players in the market, and a quick transition towards easy-to-use single-injection formulations. The growing interest in the search for non-opioid pain management options regarding chronic conditions also serves as a potent driver that prompts the demand increase in this region.

• Europe

The European Viscosupplementation Market is rising at a steady rate, which is driven by an ageing population that is increasing at an alarming rate across the leading economies of Western Europe. The growth of the market is also facilitated by the high investments in the health infrastructure, intensive research and development, which results in the regular new products and approvals. Nonetheless, the market has limitations because of various and even limiting country-specific reimbursement policies, which require manufacturers to remain cost-effective at all times.

• Asia

Asia-Pacific is expected to be the most rapidly expanding market in terms of Viscosupplementation in the world. The spurring factor behind this explosive growth is the tremendous and rapidly increasing geriatric population, the economic development occurring in many countries the resulting in the enhancement of healthcare facilities and rising awareness of non-surgical treatment in China, Japan, and India. Although the multiple-injection products are still popular because of their economical nature, the spending and healthcare infrastructure have been improving, making the use of the high-quality single-injection products more acceptable. 

KEY INDUSTRY PLAYERS

Key Players Transforming the Viscosupplementation Market Landscape through Innovation and Global Strategy

Through the innovation of strategies and market development, the market players in the field of enterprise are shaping the Viscosupplementation Market. Certain of these can be seen as advancements in designs, Products of materials, and controls, besides the use of smarter technologies for the enhancement of functionality and operational flexibility. Managers are aware of their responsibility to spend money on the development of new products and processes and expand the scope of manufacturing. This market expansion also assists in diversifying the market growth prospects and attaining higher market demand for the product in numerous industries.

List Of Top Viscosupplementation Market Management Companies

• Sanofi (France)
• Anika Therapeutics (U.S)
• Seikagaku (Japan)
• Zimmer Biomet (U.S)
• Bioventus (U.S)
• Ferring (Switzerland)
• LG Chem (South Korea)
• Freda (China)
• Haohai Biological (China)
• Shanghai Jingfeng (China)

KEY INDUSTRY DEVELOPMENT

March 2024: The release of the Integrity Implant System in 2024 represents a great strategic shift in direction by Anika Therapeutics, which utilizes the proprietary hyaluronic acid (HA) technology beyond the classical injections of Viscosupplementation into the regenerative sports medicine sector. This product is a sophisticated HA-based scaffold used to supplement surgical operations, in this case, rotator cuff tendon repair. The system will focus on the high re-tear rates of tendon surgeries with a high, porous scaffold, which promotes the natural regeneration and thickening of the tissues in the body. Its full market release reinforces the trend of utilizing the biocompatible and regenerative properties of HA in more complex, high-value orthopedic procedures.

REPORT COVERAGE

This report is based on historical analysis and forecast calculations that aim to provide readers with a comprehensive understanding of the global Viscosupplementation Market from multiple angles, thereby offering sufficient support for readers’ strategy and decision-making. Also, this study comprises a comprehensive analysis of SWOT and provides insights for future developments within the market. It examines varied factors that contribute to the market's growth by discovering the dynamic categories and potential areas of innovation whose application may influence its trajectory in the upcoming years. This analysis encompasses both recent trends and historical turning points for consideration, providing a holistic understanding of the market’s competitors and identifying capable areas for growth.

This research report examines the segmentation of the market by using both quantitative and qualitative methods to provide a thorough analysis that also evaluates the influence of strategic and financial perspectives on the market. Additionally, the report's regional assessments consider the dominant supply and demand forces that impact market growth. The competitive landscape is detailed meticulously, including shares of significant market competitors. The report incorporates unconventional research techniques, methodologies, and key strategies tailored for the anticipated frame of time. Overall, it offers valuable and comprehensive insights into the market dynamics professionally and understandably.